Inhibikase Therapeutics Provides Update to FDA Clinical Hold of IkT-148009 Programs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/18/2026

1. NVDA
2. DOO
3. HD
4. AMLX
5. METC
6. SPY
7. ARGX
8. INFQ
9. SAR

Go back to Inhibikase Therapeutics Provides Update to FDA Clinical Hold of IkT-148009 Programs
(NASDAQ: IKT) Delayed: 2.40 +0.01 (0.42%)
Previous Close $2.39    52 Week High $ 
Open $2.36    52 Week Low $ 
Day High $2.41    P/E N/A 
Day Low $2.31    EPS $ 
Volume 343,969